E Fund Management Co., Ltd. Catalyst Pharmaceuticals, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.06 Billion
- Q2 2025
A detailed history of E Fund Management Co., Ltd. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 10,656 shares of CPRX stock, worth $220,898. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,656
Previous 9,785
8.9%
Holding current value
$220,898
Previous $237,000
2.53%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding CPRX
# of Institutions
388Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$388 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$182 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$114 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$67.4 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$66 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.13B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...